Takeda Pharmaceutical Company Limited (TKPHF.PK) Thursday said its profit for the 9-month period declined nearly 50 percent to 147.1 billion yen or 94 yen per share from last year.
Excluding one-time items, core profit was 643.6 billion yen, or 412 yen per share, nearly 9 percent down from the year-ago period.
Revenue for the period, however, rose 4.6% to 3,212.9 billion yen from the previous year.
Looking forward, the company has maintained in full-year outlook for revenue of 3,980 billion yen and core EPS of 447 yen per share.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.